InvestorsHub Logo
Followers 64
Posts 2029
Boards Moderated 0
Alias Born 10/31/2017

Re: exwannabe post# 434462

Wednesday, 01/12/2022 12:19:57 PM

Wednesday, January 12, 2022 12:19:57 PM

Post# of 704201
Yep, AND I do not see any reason to change my view at this time. I may be wrong or COVID may delay things, but I am sticking to the belief that the BLA has been filed and the buzzer sounds mid-February.

The trademarked, branded DCVAX for brain tumors will be an available personalized immune therapy very soon, as it s safe and feasible to add to the Standard of Care, and all new product research approved by FDA has focussed on the much smaller and treatment resistant market of Recurrent GBM using Hybrid control models for comparison.

It is important to protect your trademarked brand, so your partners must update 9.5 year old press releases to include the registered trademark if they still wish to market their connection to DCVAX.

https://www.izi.fraunhofer.de/en/press/press-releases/fraunhofer-izi-received-manufacturing-authorization-for-dcvax-l-brain.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News